Cyanopyrimidine derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9708292
APP PUB NO 20120022077A1
SERIAL NO

12865472

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel cyanopyrimidine compound and a pharmaceutical composition which have a safe and potent adenosine A2a receptor agonistic activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OTSUKA PHARMACEUTICAL CO LTDJAPAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hino, Keisuke Osaka, JP 2 0
Ito, Kuni Osaka, JP 1 0
Michikami, Daisaku Osaka, JP 1 0
Sato, Norifumi Osaka, JP 22 135
Shinohara, Hisashi Osaka, JP 6 18
Takeji, Yasuhiro Osaka, JP 5 18
Yamazaki, Hiroyuki Osaka, JP 183 1751
Yuki, Yohei Osaka, JP 13 28

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00